Since 20–30% of myeloma patients present with some degree of renal dysfunction, there have been concerns that asymptomatic myeloma patients with elevated levels of β2-microglobulin and renal impairment do not reflect tumor burden, but rather the degree of renal dysfunction. The gene discussed is HLA-G; the disease is plasma cell myeloma.